A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor

Clinical trial NCT05021367 · UNKNOWN

Trial details

NCT number: NCT05021367
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2021-09-23
Primary completion: 2025-02-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.